Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors
Open Access
- 30 November 2024
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 29 (8) , 100198
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts Life Sciences Center
- NCI (R01 CA233800, R21 CA247671, R61 CA278449)
- Honorable Tina Brozman Foundation
- National Institutes of Health
- Mark Foundation For Cancer Research
This publication has 65 references indexed in Scilit:
- Imidazoles are Tunable Nucleofuges for Developing Tyrosine‐Reactive ElectrophilesChemBioChem, 2024
- N‐Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1Angewandte Chemie International Edition, 2024
- Ubiquitin carboxy‐terminal hydrolase L1 – physiology and pathologyCell Biochemistry and Function, 2020
- Prototyping Instruments for the Chemical Laboratory Using Inexpensive Electronic ModulesAngewandte Chemie International Edition, 2018
- multiplierz v2.0: A Python‐based ecosystem for shared access and analysis of native mass spectrometry dataProteomics, 2017
- Developing Irreversible Inhibitors of the Protein Kinase CysteinomeChemistry & Biology, 2013
- The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK)Bioorganic & Medicinal Chemistry Letters, 2012
- Structure–activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine KinaseChemMedChem, 2006
- Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell LineChemistry & Biology, 2003